Russell Investments Group’s Cumberland Pharmaceuticals CPIX Stock Holding History

Russell Investments Group’s Portfolio CPIX Stock Details CPIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-5,198	Closed	-$13K	–	3010
2021 Q3	$13K	Hold	5,198	–	–	﹤0.01%	3010
2021 Q2	$15K	Hold	5,198	–	–	﹤0.01%	3180
2021 Q1	$16K	Hold	5,198	–	–	﹤0.01%	3068
2020 Q4	$15K	Hold	5,198	–	–	﹤0.01%	2991
2020 Q3	$16K	Hold	5,198	–	–	﹤0.01%	3144
2020 Q2	$16K	Hold	5,198	–	–	﹤0.01%	3065
2020 Q1	$18K	Hold	5,198	–	–	﹤0.01%	2958
2019 Q4	$24K	Hold	5,198	–	–	﹤0.01%	3028
2019 Q3	$29K	Hold	5,198	–	–	﹤0.01%	2955
2019 Q2	$33K	Hold	5,198	–	–	﹤0.01%	2766
2019 Q1	$31K	Hold	5,198	–	–	﹤0.01%	2850
2018 Q4	$31K	Hold	5,198	–	–	﹤0.01%	2836
2018 Q3	$30K	Hold	5,198	–	–	﹤0.01%	2887
2018 Q2	$32K	Hold	5,198	–	–	﹤0.01%	2855
2018 Q1	$35K	Hold	5,198	–	–	﹤0.01%	2853
2017 Q4	$38K	Hold	5,198	–	–	﹤0.01%	2893
2017 Q3	$37K	Hold	5,198	–	–	﹤0.01%	2884
2017 Q2	$37K	Hold	5,198	–	–	﹤0.01%	2907
2017 Q1	$36K	Hold	5,198	–	–	﹤0.01%	2932
2016 Q4	$29K	Buy	+5,198	New	+$27.1K	﹤0.01%	3019

Other funds holding CPIX

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

BAM

Berkshire Asset Management Wilkes Barre, Pennsylvania $2.33B AUM 19.33% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Russell Investments Group's CPIX Position: Q4 2021 in Review

Russell Investments Group sold out of Cumberland Pharmaceuticals (CPIX) in Q4 2021, closing a stake of 5,198 shares — an estimated $13K sold.

Russell Investments Group first reported a position in CPIX in Q4 2016 and held it in 20 quarters. The position peaked at $38K in Q4 2017. 26 funds tracked by Wall St. Rank hold CPIX as of Q4 2021.

Russell Investments Group reported no remaining Cumberland Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
Russell Investments Group sold 5,198 Cumberland Pharmaceuticals shares in Q4 2021, an estimated $13K.
Russell Investments Group first reported a position in Cumberland Pharmaceuticals in Q4 2016 and held it in 20 quarters.
Russell Investments Group's Cumberland Pharmaceuticals position peaked at $38K in Q4 2017.
26 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q4 2021.

Based on Russell Investments Group's 13F filing for Q4 2021, filed 21 Jan 2022.